Plasma Oxalate Concentration and Patients With CKD

Plasma Oxalate Concentration and Patients With CKD

Bibliographic Details
Main Authors:	Yoshinari Oka, Masashi Miyazaki, Hiroaki Matsuda
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921001066

Similar Items

Author Reply to Comment on “Assessment of Plasma Oxalate Concentration in Patients With CKD” by Oka et al.
by: Anja Pfau, et al.
Published: (2021-04-01)

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease
by: Theresa Ermer, et al.
Published: (2017-11-01)

Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion
by: Joseph J. Crivelli, et al.
Published: (2020-12-01)

Influence of Oxalic Acid Concentrations on the Growth of Molybdenum Disulphide
by: Tan, Aik Leng, et al.
Published: (2017)

Molecular identification of oxalate-degrading lactobacillus in patients with calcium oxalate urolithiasis
by: Mohammad Kargar, et al.
Published: (2012-09-01)

Crosstalk between proteinuria, plasma oxalic acid and inflammation in glomerulonephritis patients: an exploratory study
by: Natalia Stepanova, et al.
Published: (2021-04-01)

Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes
by: Dustin Le, et al.
Published: (2023-11-01)

Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury
by: Daorina Bao, et al.
Published: (2023-07-01)

Ethylammonium hydrogen oxalate–oxalic acid (2/1)
by: Assane Toure, et al.
Published: (2019-05-01)

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
by: Anna Kletzmayr, et al.
Published: (2020-04-01)

Premature Senescence and Telomere Shortening Induced by Oxidative Stress From Oxalate, Calcium Oxalate Monohydrate, and Urine From Patients With Calcium Oxalate Nephrolithiasis
by: Kamonchanok Chuenwisad, et al.
Published: (2021-10-01)

Prevention of Root Caries Using Oxalic Acid
by: Hidetoshi Oguma, et al.
Published: (2023-02-01)

Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients
by: Yoko Nishizawa, et al.
Published: (2023-10-01)

Plasma oxalic acid as a trigger for oxidative processes in end-stage renal disease patients
by: L. Korol, et al.
Published: (2021-01-01)

Enrofloxacinium oxalate
by: Thammarse S. Yamuna, et al.
Published: (2014-02-01)

Seasonal changes in foliar calcium oxalate concentrations in conifer and hardwood trees: a potentially bioavailable source of cellular calcium and/or oxalate under stress
by: Rakesh Minocha, et al.
Published: (2023-06-01)

Crystal structure of dimethylammonium hydrogen oxalate hemi(oxalic acid)
by: Waly Diallo, et al.
Published: (2015-05-01)

(Dimethylphosphoryl)methanaminium hydrogen oxalate–oxalic acid (2/1)
by: Sebastian Bialek, et al.
Published: (2014-03-01)

CKD-Associated Pruritus and Clinical Outcomes in Nondialysis CKD
by: Jennifer S. Scherer, et al.
Published: (2024-01-01)

Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
by: Natsumi Uchiyama-Matsuoka, et al.
Published: (2022-11-01)

Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones.
by: Mihoko Maruyama, et al.
Published: (2023-01-01)

Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones
by: Mihoko Maruyama, et al.
Published: (2023-01-01)

Bi-allelic REN Mutations and Undetectable Plasma Renin Activity in a Patient With Progressive CKD
by: Sofia Jorge, et al.
Published: (2023-05-01)

The Production of Oxalate by <i>Aspergillus niger</i> under Different Lead Concentrations
by: Yijun Huang, et al.
Published: (2023-04-01)

Interaction of Celestine Concentrate and Reagent Grade SrSO4 with Oxalate Solutions
by: Abdullah Obut
Published: (2012-12-01)

Comparative performance of FAS equation and Asian modified CKD-EPI in the determination of GFR in Chinese patients with CKD with the 99mTc-DTPA plasma clearance as the reference method
by: Jian-Qing Gao, et al.
Published: (2021-01-01)

Comparative performance of FAS equation and Asian modified CKD-EPI in the determination of GFR in Chinese patients with CKD with the 99mTc-DTPA plasma clearance as the reference method
by: Jian-Qing Gao, et al.
Published: (2021-01-01)

Study of calcium oxalate nanocrystalline structures and kinetics of calcium oxalate deposition
by: O.A. Golovanova
Published: (2022-12-01)

Constipation in CKD
by: Keiichi Sumida, et al.
Published: (2020-02-01)

The Higher the CKD Stage, the Higher the Psychological Stress in Patients with CKD during COVID-19 Pandemic
by: Kyung-Mi Lee, et al.
Published: (2022-08-01)

Association of obesity with mortality in patients with various stages of non-dialysis dependent CKD (NDD-CKD)
by: Csaba P Kovesdy, et al.
Published: (2012-06-01)

Potassium Metabolism and Management in Patients with CKD
by: Shinsuke Yamada, et al.
Published: (2021-05-01)

Energy Requirement for Elderly CKD Patients
by: Claudia D’Alessandro, et al.
Published: (2021-09-01)

Editorial: Personalized medicine in CKD patients
by: Michele F. Eisenga, et al.
Published: (2023-08-01)

Strategies for Phosphate Control in Patients With CKD
by: Fellype Carvalho Barreto, et al.
Published: (2019-08-01)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
by: Delphine S. Tuot, et al.
Published: (2019-03-01)

Poisoned by oxalic acid.
by: Clarke, M
Published: (1990)

Creatinium hydrogen oxalate
by: A. Jahubar Ali, et al.
Published: (2012-02-01)

Tetraphenylphosphonium hydrogen oxalate
by: Philip A. W. Dean, et al.
Published: (2008-01-01)

Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease
by: Coresh Josef, et al.
Published: (2011-01-01)